StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)

Close on Nov 17, 2026Market cap $250.73MP/E –Yield –

USANA Health Sciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

USANA Health Sciences's pe ratio was 47.0× on Jul 31, 2026, against 16.1× a year earlier. Over the last 5 years it ranged from 11.5× to 47.0×, with a median of 14.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202647.0×+24.7
2025Dec 31, 202522.3×+9.6
2024Dec 31, 202412.7×−4.7
2023Dec 29, 202317.3×+3.9
2022Dec 30, 202213.4×−2.0
2021Dec 31, 202115.4×+1.2
2020Dec 31, 202014.3×−3.9
2019Dec 31, 201918.1×−15.0
2018Dec 31, 201833.2×+12.8
2017Dec 29, 201720.4×+5.3
2016Dec 30, 201615.1×−3.1
2015Dec 31, 201518.3×−0.8
2014Dec 31, 201419.0×+5.1
2013Dec 31, 201313.9×+5.8
2012Dec 31, 20128.1×−1.5
2011Dec 30, 20119.6×−10.4
2010Dec 31, 201020.0×–

More USANA Health Sciences figures

See a number that looks wrong?